Edmund Lee

Edmund Lee

Company: Regulus Therapeutics

Job title: Executive Director, Biology


Inhibition of miR-17 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 9:30 am

Investigating preclinical data supporting miR-17 as therapeutic target for ADPKD Assessing translational research leading up to the development of clinically-relevant urinary biomarker for ADPKD Exploring clinical data demonstrating target engagement and proof of mechanism in ADPKD patientsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.